Securities Registration: Employee Benefit Plan (s-8)
June 23 2017 - 4:48PM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT UNDER
THE SECURITIES ACT OF 1933
ADAMIS PHARMACEUTICALS CORPORATION
(Exact Name of Registrant as Specified in Its Charter)
Delaware
|
82-0429727
|
(State
or Other Jurisdiction
of
Incorporation or Organization)
|
(I.R.S.
Employer
Identification No.)
|
11682
El Camino Real, Suite 300
San
Diego, CA 92130
(Address
of Principal Executive Offices)
Adamis
Pharmaceuticals Corporation
2009
Equity Incentive Plan
(Full
Title of the Plan)
Robert
O. Hopkins
Chief Financial Officer
Adamis Pharmaceuticals Corporation
11682
El Camino Real, Suite 300
San
Diego, CA 92130
(858) 997-2400
(Name,
Address and Telephone Number of Agent For Service)
Copies
to:
C. Kevin Kelso, Esq.
Weintraub Tobin Chediak Coleman Grodin Law Corporation
400 Capitol Mall, Suite 1100
Sacramento, CA 95814
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller
reporting company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller
reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer
|
|
☐
|
|
Accelerated filer
|
|
☐
|
|
|
|
|
Non-accelerated filer
|
|
☐ (Do not check
if a smaller reporting company)
|
|
Smaller reporting company
|
|
☒
|
|
|
|
|
Emerging growth company
|
|
☐
|
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.
☐
CALCULATION
OF REGISTRATION FEE
Title of Securities
to be Registered
|
|
Amount
to be
Registered
(2)
|
|
Proposed
Maximum
Offering Price
Per Share
|
|
Proposed
Maximum
Aggregate
Offering Price
|
|
Amount
of
Registration
Fee
|
Common Stock, $0.0001 par value, to be issued under the 2009 Equity Incentive Plan (
“Plan”
)
|
|
|
1,099,577
|
(3)
|
|
$
|
4.85
|
(1)
|
|
$
|
5,332,948.45
|
|
|
$
|
618.09
|
|
(1)
|
Estimated
pursuant to Rule 457(c) under the Securities Act of 1933, as amended, based on the average of the high and low prices per
share of the common stock of the Registrant on June 21, 2017, as reported on The NASDAQ Capital Market on June
21, 2017.
|
(2)
|
Pursuant
to Rule 416(a), this Registration Statement also covers any additional securities that may be offered or issued in connection
with any stock split, stock dividend or similar transaction.
|
(3)
|
Includes
shares that were automatically added to the shares authorized for issuance under the Plan pursuant to the Evergreen Provision
(defined below) of the 2009 Equity Incentive Plan (the “Plan”).
|
EXPLANATORY
NOTE
Pursuant
to General Instruction E to Form S-8 under the Securities Act of 1933 (the
”Securities Act”
), this
Registration Statement is filed by Adamis Pharmaceuticals Corporation (the
”Registrant”
or
the “
Company
”) for the purpose of registering additional shares of Common Stock under the Plan. The
basis for this calculation is as follows. The Plan provides that an additional number of shares will automatically be added annually
to the 411,765 shares initially authorized for issuance under the Plan on January 1, from 2010 until 2019. The number of
shares added each year will be equal to (i) five percent (5%) of the total number of shares of Common Stock outstanding on
December 31st of the preceding calendar year, or (ii) a lesser number of shares of Common Stock determined by the Board
of Directors before the start of a calendar year for which an increase applies (the
”Evergreen Provision”
).
Accordingly, the number of shares of Common Stock available for issuance under the Plan was increased by 1,099,577 shares effective
January 1, 2017. Accordingly, this Registration Statement registers 1,099,577
additional shares of Common Stock available for issuance under the Plan as a result of such increase and the Evergreen Provisions.
The
shares of Common Stock registered pursuant to this Registration Statement are of the same class of securities as the (i) 411,765
shares of Common Stock registered for issuance under the Plan pursuant to the currently effective Registration Statement on Form
S-8 (Registration No. 333-159229) originally filed on May 13, 2009 (the
”Original Registration Statement”
),
(ii) 136,938 shares of Common Stock registered for issuance under the Plan pursuant to the currently effective Registration Statement
on Form S-8 (Registration Number 333-169106) originally filed on August 30, 2010 (the “
Second Registration Statement
”),
(iii) 239,972 shares of Common Stock registered for issuance under the Plan pursuant to the currently effective Registration Statement
on Form S-8 (Registration Number 333-175383) originally filed on July 7, 2011 (the “
Third Registration Statement
”),
(iv) the 1,073,977 shares of Common Stock registered for issuance under the Plan pursuant to the currently effective Registration
Statement on Form S-8 (Registration Number 333-194635) originally filed on March 17, 2014 (the “
Fourth Registration
Statement
”), (v) the 1,532,597 shares of Common Stock registered for issuance under the Plan pursuant to the currently
effective Registration Statement on Form S-8 (Registration Number 333-201742) originally filed on January 29, 2015 (the “
Fifth
Registration Statement
”), and (vi) the 5,171,583 shares of Common Stock registered for issuance under the Plan pursuant
to the currently effective Registration Statement on Form S-8 (Registration Number 333-211773) originally filed on June 2, 2016
(the “
Sixth Registration Statement
”). The contents of the Original Registration Statement, the Second
Registration Statement, the Third Registration Statement, the Fourth Registration Statement, the Fifth Registration Statement
and the Sixth Registration Statement, including any amendments thereto or filings incorporated therein, are incorporated herein
by this reference. Any items in the Original Registration Statement, the Second Registration Statement, the Third Registration
Statement, the Fourth Registration Statement, the Fifth Registration Statement and the Sixth Registration Statement, not expressly
changed hereby shall be as set forth in the Original Registration Statement, the Second Registration Statement, the Third Registration
Statement, the Fourth Registration Statement, the Fifth Registration Statement and the Sixth Registration Statement, as applicable.
On
December 12, 2013, the Company effected a 1-for-17 reverse stock split of the Company’s issued and outstanding Common Stock.
In connection with the reverse stock split, the total number of shares then-authorized for issuance under the Plan decreased proportionately
to reflect the reverse stock split. The share totals contained in this Registration Statement reflect the 1-for-17 reverse stock
split.
PART
I
INFORMATION
REQUIRED IN THE REGISTRATION STATEMENT
ITEM
1.
|
REGISTRANT
INFORMATION AND EMPLOYEE PLAN INFORMATION
|
Not
required to be filed with this Registration Statement.
ITEM
2.
|
REGISTRANT
INFORMATION AND EMPLOYEE PLAN INFORMATION
|
Not
required to be filed with this Registration Statement.
PART
II
INFORMATION
REQUIRED IN THE REGISTRATION STATEMENT
ITEM
3.
|
INFORMATION
INCORPORATED BY REFERENCE.
|
The
Registrant hereby incorporates by reference into this Registration Statement the following documents and information previously
filed with the Securities and Exchange Commission (
“Commission”
):
|
(a)
|
The
Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2016.
|
|
|
|
|
(b)
|
All
other reports filed pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as
amended(the
”Exchange Act”
), since the end of the fiscal year covered by the annual report
referred to in (a) above.
|
|
|
|
|
(c)
|
The
description of the Registrant’s Common Stock contained in the Registrant’s registration statement on Form 8-A
(Reg. No. 000-26372) filed with the Commission on September 7, 2004 and registration statement on Form 8-A (Reg. No.
001-36242) filed with the Commission on December 11, 2013 under Section 12 of the Exchange Act, including any amendment or
report filed for the purpose of updating such description.
|
|
|
|
|
(d)
|
All
documents that we subsequently file under Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act before we file a
post-effective amendment which indicates that all securities offered have been sold or which deregisters all securities then
remaining unsold, shall be deemed to be incorporated by reference in this Registration Statement and to be a part hereof from
the date of filing of such documents, except as to specific sections of such statements as set forth therein. Unless
expressly incorporated into this Registration Statement, a report furnished on Form 8-K prior or subsequent to the date
hereof, shall not be incorporated by reference into this Registration Statement.
|
Any
statement incorporated herein shall be deemed to be modified or superseded for the purposes of this Registration Statement to
the extent that a statement contained herein or in any other subsequently filed document that is or is deemed to be incorporated
by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except
as so modified or superseded, to constitute a part of this Registration Statement.
ITEM
4.
|
DESCRIPTION
OF SECURITIES.
|
Not
applicable.
ITEM
5.
|
INTERESTS
OF NAMED EXPERTS AND COUNSEL.
|
Not
applicable.
ITEM
6.
|
INDEMNIFICATION
OF DIRECTORS AND OFFICERS.
|
The
Registrant is incorporated under the laws of the State of Delaware. Section 145 of the Delaware General Corporation Law provides
that a Delaware corporation may indemnify any persons who are, or are threatened to be made, parties to any threatened, pending
or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or
in the right of such corporation), by reason of the fact that such person was an officer, director, employee or agent of such
corporation, or is or was serving at the request of such person as an officer, director, employee or agent of another corporation
or enterprise. The indemnity may include expenses (including attorneys’ fees), judgments, fines and amounts paid in
settlement actually and reasonably incurred by such person in connection with such action, suit or proceeding, provided that such
person acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the corporation’s best
interests and, with respect to any criminal action or proceeding, had no reasonable cause to believe that his or her conduct was
illegal. Where an officer or director is successful on the merits or otherwise in the defense of any action referred to above,
the corporation must indemnify him or her against the expenses, which such officer or director has actually and reasonably incurred.
The Registrant’s amended and restated certificate of incorporation and amended and restated bylaws provide for the indemnification
of its directors and officers to the fullest extent permitted under the Delaware General Corporation Law.
Registrant
has entered into Indemnity Agreements with its current directors to give such directors additional contractual assurances regarding
the scope of the indemnification set forth in the amended and restated certificate of incorporation and to provide additional
procedural protections.
See
also the undertakings set out in response to Item 9.
The
indemnification provisions in the Registrant’s Bylaws and the Indemnity Agreements described above may be sufficiently broad
to indemnify such individuals, under certain circumstances, for liabilities (including reimbursement of expenses incurred) arising
under the Securities Act.
ITEM
7.
|
EXEMPTION
FROM REGISTRATION CLAIMED.
|
Not
applicable.
The
following documents are filed as exhibits to this Registration Statement:
Exhibit
No.
|
|
Description
|
4.01
|
|
Restated
Certificate of Incorporation (Incorporated by reference to exhibits filed with the Company’s registration statement on Form
S-8, file no. 333-194635, filed on March 17, 2014.).
|
|
|
|
4.02
|
|
Certificate
of Designation of Preferences, Rights and Limitations of Series A Convertible Preferred Stock. (Incorporated by reference
to exhibits filed with the Report on Form 8-K, filed on August 20, 2014.)
|
|
|
|
4.03
|
|
Certificate
of Designation of Preferences, Rights and Limitations of Series A-1 Convertible Preferred Stock. (Incorporated by reference
to exhibits filed with the Report on Form 8-K, filed on January 26, 2016).
|
|
|
|
4.04
|
|
Amended
and Restated Bylaws of the Company (incorporated herein by reference to exhibits previously filed on Form S-4/A filed
January 12, 2009, file no. 333-155322).
|
|
|
|
4.05
|
|
Adamis
Pharmaceuticals Corporation 2009 Equity Incentive Plan (incorporated herein by reference to exhibits filed with the Company’s
Quarterly Report on Form 10-Q, filed November 14, 2014).
|
|
|
|
4.06
|
|
Form
of Option Agreements under 2009 Equity Incentive Plan (incorporated by reference to exhibits filed with the Form 8-K, filed
on September 16, 2011.
|
|
|
|
4.07
|
|
Form
of Restricted Stock Unit Award Grant Notice and Award Agreement under 2009 Equity Incentive Plan. (incorporated by reference
to exhibits filed with the Registration Statement on Form S-8, file no. 333-194635, filed March 17,
2014).
|
|
|
|
4.08
|
|
Form
of Restricted Stock Unit Award Grant Notice and Award Agreement for Non-Employee Directors under 2009 Equity Incentive Plan.
(incorporated by reference to exhibits filed with the Registration Statement on Form S-8, file no. 333-194635, filed March
17, 2014).
|
|
|
|
4.09
|
|
Form
of Option Agreement for Non-Employee Directors (incorporated by reference to exhibits filed with the Report on Form 8-K,
filed January 13, 2011).
|
|
|
|
5.01
|
|
Opinion of Weintraub Tobin Chediak Coleman Grodin Law Corporation.
|
|
|
|
23.01
|
|
Consent of Mayer Hoffman McCann P.C., Independent Registered Public Accounting Firm.
|
|
|
|
23.02
|
|
Consent of Hudson Cisne & Co. LLP, Independent Registered Public Accounting Firm
|
|
|
|
23.03
|
|
Consent of Weintraub Tobin Chediak Coleman Grodin Law Corporation (included in Exhibit 5.01).
|
|
|
|
24.01
|
|
Power
of Attorney (see signature page).
|
The
undersigned Registrant hereby undertakes:
(1)
To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:
(i) to include any prospectus required by Section 10(a)(3) of the Securities Act; (ii) to reflect in the prospectus any facts
or events arising after the effective date of the Registration Statement (or the most recent post-effective amendment thereof)
which, individually or in the aggregate, represent a fundamental change in the information in the Registration Statement; and
(iii) to include any material information with respect to the plan of distribution not previously disclosed in the Registration
Statement or any material change to such information in the Registration Statement; provided, however, that (i) and (ii) do not
apply if the information required to be included in a post-effective amendment thereby is contained in periodic reports filed
by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference into the
Registration Statement.
(2)
That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed
to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time
shall be deemed to be the initial bona fide offering thereof.
(3)
To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold
at the termination of the offering.
(4)
That, for purposes of determining any liability under the Securities Act, each filing of the Registrant’s annual report
pursuant to Section 13(a) or Section 15(d) of the Exchange Act that is incorporated by reference in this Registration Statement
shall be deemed to be a new Registration Statement relating to the securities offered therein, and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof.
Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons
of the Registrant pursuant to the provisions described under Item 6 above, or otherwise, the Registrant has been advised that
in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore,
unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant
of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action,
suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered,
the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court
of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities
Act and will be governed by the final adjudication of such issue.
SIGNATURES
Pursuant
to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it
meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf
by the undersigned, thereunto duly authorized, in the City of San Diego, California, on this 23
rd
day of June, 2017.
POWER
OF ATTORNEY
KNOW
ALL BY THESE PRESENTS that each individual whose signature appears below constitutes and appoints Dennis J. Carlo and Robert O.
Hopkins, and each of them, his attorneys-in-fact, and agents, each with the power of substitution, for him and in his name, place
and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration
Statement, and to file the same, with all exhibits thereto and all documents in connection therewith, with the Securities and
Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform
each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes
as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them,
or his or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof. This Power of Attorney may be
signed in one or more counterparts.
Pursuant
to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the
capacities and on the dates indicated.
Name
|
|
Title
|
|
Date
|
Principal Executive
Officer:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/
Dennis J. Carlo
|
|
Chief Executive Officer
and Director
|
|
June
23, 2017
|
Dennis J. Carlo, Ph.D.
|
|
|
|
|
|
|
|
|
|
Principal Financial
Officer
|
|
|
|
|
and Principal Accounting
Officer:
|
|
|
|
|
|
|
|
|
|
/s/
Robert O. Hopkins
|
|
Vice President, Finance,
Chief Financial Officer
|
|
June
23, 2017
|
Robert O. Hopkins
|
|
and Secretary
|
|
|
|
|
|
|
|
Directors:
|
|
|
|
|
|
|
|
|
|
/s/
David J. Marguglio
|
|
Director
|
|
June
23, 2017
|
David J. Marguglio
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/
William C. Denby, III
|
|
Director
|
|
June
23, 2017
|
William C. Denby,
III
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/
Robert B. Rothermel
|
|
Director
|
|
June
23, 2017
|
Robert B. Rothermel
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/
Richard C. Williams
|
|
Director
|
|
June
23, 2017
|
Richard C. Williams
|
|
|
|
|
Adamis Pharmaceuticals (NASDAQ:ADMP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Adamis Pharmaceuticals (NASDAQ:ADMP)
Historical Stock Chart
From Apr 2023 to Apr 2024